CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems (Q40569367)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 2004

Language	Label	Description	Also known as
English	CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems	scientific article published on April 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

James P. Allison

12

object named as

James P Allison

0 references

Miguel-Angel Perales

object named as

Miguel-Angel Perales

6

0 references

Jedd D. Wolchok

2

object named as

Jedd D Wolchok

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

13

object named as

Howard I Scher

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Polly D Gregor

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Cristina R Ferrone

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Heidi Buchinshky

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Jose A Guevara-Patiño

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Fariborz Mortazavi

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dean Bacich

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Warren Heston

9

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Jean-Baptiste Latouche

10

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Michel Sadelain

11

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Alan N Houghton

14

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

13-14

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1700-1708

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Cancer antigens: immune recognition of self and altered self

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Intracellular sorting and targeting of melanosomal membrane proteins: identification of signals for sorting of the human brown locus protein, gp75

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immune response to a differentiation antigen induced by altered antigen: a study of tumor rejection and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Tumor immunity and autoimmunity induced by immunization with homologous DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Coupling and uncoupling of tumor immunity and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Vaccine therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Cytokines and costimulatory molecules as genetic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Next generation DNA vaccines for HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

The role of CTLA-4 in the regulation and initiation of T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Pathologic progression of autochthonous prostate cancer in the TRAMP model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

The role of lipopolysaccharide in T-cell responses following DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

Selection of Successive Tumour Lines for Metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

based on heuristic

inferred from DOI database lookup

Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.048

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.10.048

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40569367&oldid=2185989271"